Whelihan Matthew F, Kiankhooy Armin, Brummel-Ziedins Kathleen E
Departments of Biochemistry and Surgery, College of Medicine, University of Vermont, Burlington, VT.
J Crit Care. 2014 Feb;29(1):24-30. doi: 10.1016/j.jcrc.2013.10.010. Epub 2013 Oct 29.
Despite trauma-induced hypothermic coagulopathy being familiar in the clinical setting, empirical experimentation concerning this phenomenon is lacking. In this study, we investigated the effects of hypothermia on thrombin generation, clot formation, and global hemostatic functions in an in vitro environment using a whole blood model and thromboelastography, which can recapitulate hypothermia.
Blood was collected from healthy individuals through venipuncture and treated with corn trypsin inhibitor, to block the contact pathway. Coagulation was initiated with 5pM tissue factor at temperatures 37°C, 32°C, and 27°C. Reactions were quenched over time, with soluble and insoluble components analyzed for thrombin generation, fibrinogen consumption, factor (f)XIII activation, and fibrin deposition. Global coagulation potential was evaluated through thromboelastography.
Data showed that thrombin generation in samples at 37°C and 32°C had comparable rates, whereas 27°C had a much lower rate (39.2 ± 1.1 and 43 ± 2.4 nM/min vs 28.6 ± 4.4 nM/min, respectively). Fibrinogen consumption and fXIII activation were highest at 37°C, followed by 32°C and 27°C. Fibrin formation as seen through clot weights also followed this trend. Thromboelastography data showed that clot formation was fastest in samples at 37°C and lowest at 27°C. Maximum clot strength was similar for each temperature. Also, percent lysis of clots was highest at 37°C followed by 32°C and then 27°C.
Induced hypothermic conditions directly affect the rate of thrombin generation and clot formation, whereas global clot stability remains intact.
尽管创伤性低温凝血障碍在临床环境中较为常见,但针对这一现象的实证研究却很缺乏。在本研究中,我们使用全血模型和血栓弹力图,在体外环境中研究了低温对凝血酶生成、血凝块形成及整体止血功能的影响,该模型能够模拟低温状态。
通过静脉穿刺从健康个体采集血液,并用玉米胰蛋白酶抑制剂进行处理,以阻断接触途径。在37°C、32°C和27°C的温度下,用5pM组织因子启动凝血过程。随着时间的推移终止反应,分析可溶性和不溶性成分的凝血酶生成、纤维蛋白原消耗、因子(f)XIII激活和纤维蛋白沉积情况。通过血栓弹力图评估整体凝血潜能。
数据显示,37°C和32°C样本中的凝血酶生成速率相当,而27°C时的速率则低得多(分别为39.2±1.1和43±2.4 nM/分钟,对比28.6±4.4 nM/分钟)。纤维蛋白原消耗和fXIII激活在37°C时最高,其次是32°C和27°C。通过血凝块重量观察到的纤维蛋白形成也遵循这一趋势。血栓弹力图数据显示,37°C样本中的血凝块形成最快,27°C时最慢。每个温度下的最大血凝块强度相似。此外,血凝块的溶解百分比在37°C时最高,其次是32°C,然后是27°C。
诱导的低温条件直接影响凝血酶生成速率和血凝块形成,而整体血凝块稳定性保持不变。